PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase in glioma models

Por Sun, Shanyue, Du, Guangying, Xue, Jiang, Ma, Jinbo, Ge, Minmin, Wang, Hongbo, Tian, Jingwei
Publicado no Int J Immunopathol Pharmacol (2018)

PCC0208018 exerts antitumor effects by activating effector T cells

Por Ge, Minmin, Hu, Zhengping, Chen, Xiao, Du, Guangying, Wang, Hongbo, Liu, Rumeng, Ye, Liang, Tian, Jingwei
Publicado no Int J Immunopathol Pharmacol (2019)